Psychiatry South

(NIH). National Institute of Health. Intro to PROMIS®. [cited 2024 March 4th]; Available from: https://www.healthmeasures.net/explore-measurement-systems/promis/intro-to-promis Pilkonis PA, Choi SW, Reise SP, Stover AM, Riley WT, Cella D; PROMIS Cooperative Group. Item banks for measuring emotional distress from the Patient-Reported Outcomes Measurement Information System (PROMIS®): depression, anxiety, and anger. Assessment. 2011;18(3):263–283.

The current research is a secondary analysis of a randomized controlled trial that included 291 participants with major depressive disorder, panic disorder, agoraphobia, or social phobia. The trial tested the relative effects of the transdiagnostic UP [22, 30] in a group format and dCBT in a group format, evaluated by participants’ subjective well-being, symptoms, and psychosocial functioning at the end of treatment. The results indicated non-inferiority between the interventions on all outcomes.

This was a two-armed, investigator-initiated, single-blinded, parallel, randomized, controlled feasibility and superiority trial comparing the effect of pre-treatment MCA with AAU. A protocol for the current trial was published prior to its finalization [49]. A flowchart is provided in Fig. 1. The trial was registered on the ClinicalTrials.gov website (ID NCT05018312).